221 related articles for article (PubMed ID: 15693848)
1. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
[TBL] [Abstract][Full Text] [Related]
2. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
[TBL] [Abstract][Full Text] [Related]
3. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
4. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
[TBL] [Abstract][Full Text] [Related]
5. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
Gattei V; Aldinucci D; Quinn JM; Degan M; Cozzi M; Perin V; Iuliis AD; Juzbasic S; Improta S; Athanasou NA; Ashman LK; Pinto A
Cell Growth Differ; 1996 Jun; 7(6):753-63. PubMed ID: 8780889
[TBL] [Abstract][Full Text] [Related]
6. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
7. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
9. Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).
Rochet N; Dubousset J; Mazeau C; Zanghellini E; Farges MF; de Novion HS; Chompret A; Delpech B; Cattan N; Frenay M; Gioanni J
Int J Cancer; 1999 Jul; 82(2):282-5. PubMed ID: 10389764
[TBL] [Abstract][Full Text] [Related]
10. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of cell lines derived from a human osteosarcoma.
Yamane T
Clin Orthop Relat Res; 1985 Oct; (199):261-71. PubMed ID: 3862491
[TBL] [Abstract][Full Text] [Related]
14. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor-KIT signalling plays a pivotal role in regulating pigmentation in mammalian hair.
Hachiya A; Sriwiriyanont P; Kobayashi T; Nagasawa A; Yoshida H; Ohuchi A; Kitahara T; Visscher MO; Takema Y; Tsuboi R; Boissy RE
J Pathol; 2009 May; 218(1):30-9. PubMed ID: 19214986
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases.
Loukopoulos P; O'Brien T; Ghoddusi M; Mungall BA; Robinson WF
Res Vet Sci; 2004 Oct; 77(2):131-41. PubMed ID: 15196903
[TBL] [Abstract][Full Text] [Related]
17. Blocking SCF/c-Kit signal did not inhibit the proliferation of cultured liver progenitor cells.
Jin C; Li W; Xu F; Zhu J; He Z; Hu Y
IUBMB Life; 2007 Jul; 59(7):458-64. PubMed ID: 17654122
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines.
Strippoli P; Bagnara GP; Montanaro L; Timeus F; Ferreri AM; Rocchi P
Anticancer Res; 2000; 20(6B):4361-6. PubMed ID: 11205272
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
20. [Apoptosis antagonizing transcription factor is a gene highly expressed in highly metastatic human osteosarcoma cell lines].
Yin JN; Fan QY; Hao XB; Yang N
Ai Zheng; 2002 Feb; 21(2):127-31. PubMed ID: 12479059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
